AR116428A1 - Compuestos de 6-fluoro-2-metilbenzo[d]tiazol-5-ilo - Google Patents
Compuestos de 6-fluoro-2-metilbenzo[d]tiazol-5-iloInfo
- Publication number
- AR116428A1 AR116428A1 ARP190102645A ARP190102645A AR116428A1 AR 116428 A1 AR116428 A1 AR 116428A1 AR P190102645 A ARP190102645 A AR P190102645A AR P190102645 A ARP190102645 A AR P190102645A AR 116428 A1 AR116428 A1 AR 116428A1
- Authority
- AR
- Argentina
- Prior art keywords
- methylbenzo
- ilo
- thiazol
- fluoro
- compounds
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hospice & Palliative Care (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Psychiatry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862736588P | 2018-09-26 | 2018-09-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR116428A1 true AR116428A1 (es) | 2021-05-05 |
Family
ID=68085016
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP190102645A AR116428A1 (es) | 2018-09-26 | 2019-09-18 | Compuestos de 6-fluoro-2-metilbenzo[d]tiazol-5-ilo |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US10752632B2 (https=) |
| EP (1) | EP3856739A1 (https=) |
| JP (2) | JP7081047B2 (https=) |
| CN (1) | CN112955446B (https=) |
| AR (1) | AR116428A1 (https=) |
| CA (1) | CA3113968C (https=) |
| TW (1) | TWI716107B (https=) |
| WO (1) | WO2020068530A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI716107B (zh) * | 2018-09-26 | 2021-01-11 | 美商美國禮來大藥廠 | 6-氟-2-甲基苯并[d]噻唑-5-基化合物 |
| US20240043418A1 (en) * | 2020-03-26 | 2024-02-08 | Richter Gedeon Nyrt. | 1,3-dihydro-2h-pyrrolo[3,4-c]pyridine derivatives as gabaa a5 receptor modulators |
| WO2024081775A1 (en) | 2022-10-14 | 2024-04-18 | Eli Lilly And Company | Synthesis of 6-fluoro-2-methylbenzo[d]thiazol-5-yl compounds |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8726763D0 (en) | 1987-11-16 | 1987-12-23 | Fujisawa Pharmaceutical Co | Thiazole compounds |
| TW504510B (en) * | 1996-05-10 | 2002-10-01 | Janssen Pharmaceutica Nv | 2,4-diaminopyrimidine derivatives |
| SE0302116D0 (sv) | 2003-07-21 | 2003-07-21 | Astrazeneca Ab | Novel compounds |
| WO2011140640A1 (en) | 2010-05-11 | 2011-11-17 | Simon Fraser University | Selective glycosidase inhibitors and uses thereof |
| RS58768B1 (sr) | 2013-03-14 | 2019-06-28 | Merck Patent Gmbh | Inhibitori glikozidaze |
| KR102043337B1 (ko) * | 2014-08-28 | 2019-11-11 | 아셰뉴론 에스아 | 글리코시다제 저해제 |
| CN107428762B (zh) | 2015-10-30 | 2020-03-10 | 四川科伦博泰生物医药股份有限公司 | 酞嗪酮衍生物、其制备方法及用途 |
| EP3389658B1 (en) | 2015-12-18 | 2020-11-25 | Merck Sharp & Dohme Corp. | Glycosidase inhibitors and uses thereof |
| FR3046053B1 (fr) | 2015-12-24 | 2017-12-22 | Sagem Defense Securite | Module de pied pour une structure d'exosquelette |
| KR20180132629A (ko) * | 2016-02-25 | 2018-12-12 | 아셰뉴론 에스아 | 글리코시다제 저해제 |
| CA3045957A1 (en) * | 2016-12-16 | 2018-06-21 | Janssen Pharmaceutica Nv | Monocyclic oga inhibitor compounds |
| US20190359609A1 (en) * | 2016-12-16 | 2019-11-28 | Janssen Pharmaceutica Nv | Bicyclic oga inhibitor compounds |
| TWI654978B (zh) | 2017-01-27 | 2019-04-01 | 美商美國禮來大藥廠 | 5－甲基－1,2,4－二唑－3－基化合物 |
| TWI669302B (zh) | 2017-05-25 | 2019-08-21 | 美商美國禮來大藥廠 | 5-甲基-1,3,4-<img align="absmiddle" height="18px" width="27px" file="d10999.TIF" alt="其他非圖式 ed10999.png" img-content="tif" orientation="portrait" inline="yes" giffile="ed10999.png"></img>二唑-2-基化合物 |
| TWI716107B (zh) | 2018-09-26 | 2021-01-11 | 美商美國禮來大藥廠 | 6-氟-2-甲基苯并[d]噻唑-5-基化合物 |
-
2019
- 2019-09-17 TW TW108133388A patent/TWI716107B/zh active
- 2019-09-18 AR ARP190102645A patent/AR116428A1/es unknown
- 2019-09-19 JP JP2021516782A patent/JP7081047B2/ja active Active
- 2019-09-19 CN CN201980062923.0A patent/CN112955446B/zh active Active
- 2019-09-19 EP EP19779722.8A patent/EP3856739A1/en active Pending
- 2019-09-19 US US16/576,080 patent/US10752632B2/en active Active
- 2019-09-19 CA CA3113968A patent/CA3113968C/en active Active
- 2019-09-19 WO PCT/US2019/051820 patent/WO2020068530A1/en not_active Ceased
-
2020
- 2020-07-28 US US16/940,504 patent/US10836773B1/en active Active
-
2022
- 2022-05-25 JP JP2022085223A patent/JP7560511B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2022116171A (ja) | 2022-08-09 |
| JP7081047B2 (ja) | 2022-06-06 |
| US20200354370A1 (en) | 2020-11-12 |
| TWI716107B (zh) | 2021-01-11 |
| US20200095254A1 (en) | 2020-03-26 |
| CN112955446A (zh) | 2021-06-11 |
| JP2022502389A (ja) | 2022-01-11 |
| EP3856739A1 (en) | 2021-08-04 |
| JP7560511B2 (ja) | 2024-10-02 |
| CN112955446B (zh) | 2024-07-12 |
| WO2020068530A1 (en) | 2020-04-02 |
| US10752632B2 (en) | 2020-08-25 |
| CA3113968A1 (en) | 2020-04-02 |
| US10836773B1 (en) | 2020-11-17 |
| TW202026293A (zh) | 2020-07-16 |
| CA3113968C (en) | 2023-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2022008968A2 (es) | Nuevos derivados de metilquinazolinona | |
| ECSP24026637A (es) | Derivados de 3-(5-hidroxi-1-oxoisoindolin-2-il)piperidina-2,6-diona | |
| AR115949A1 (es) | Compuestos heterocíclicos | |
| ECSP20044709A (es) | Inhibidores de sarcómero cardíaco | |
| AR121226A1 (es) | Compuestos y usos de estos | |
| AR119672A1 (es) | Inhibidor de 15-pgdh | |
| MX2021000795A (es) | Compuestos heterociclicos para inhibir la actividad de shp2. | |
| AR114803A1 (es) | Compuestos de 4-aminoisoindolin-1,3-diona sustituida, composiciones de estos y métodos de tratamiento con dichos compuestos | |
| MX2021013075A (es) | Oxisteroles y metodos de uso de los mismos. | |
| AR105238A1 (es) | Compuestos de benzoxacepina oxazolidinona y métodos de uso | |
| AR117920A1 (es) | Inhibidores de la replicación del virus de la inmunodeficiencia humana | |
| MX2020003383A (es) | Compuesto de griseofulvina y uso farmacéutico de este. | |
| AR116428A1 (es) | Compuestos de 6-fluoro-2-metilbenzo[d]tiazol-5-ilo | |
| CL2022001353A1 (es) | Inhibidores de egfr | |
| AR114467A1 (es) | Moduladores alostéricos positivos del receptor de dopamina d1 | |
| MX2024003130A (es) | Amida 1,4-dihidro-1,6-naftiridina sustituida y uso de la misma. | |
| DOP2024000077A (es) | Compuestos de cd73 | |
| CL2023001440A1 (es) | Nuevos derivados de indazol acetileno | |
| PE20230182A1 (es) | Uso y composicion farmaceutica de derivados de fenilisoxazolil metilen-naftaleno-eter | |
| PH12021552953A1 (en) | Tricyclic compounds | |
| AR118141A1 (es) | Compuestos para el tratamiento, alivio o prevención de trastornos asociados con los agregados de tau | |
| AR110770A1 (es) | Moduladores del canal de potasio | |
| MX2023015440A (es) | Compuesto de sulfoximina y uso del mismo. | |
| CL2022000893A1 (es) | Derivados de 2-azaspiro[3,4]octano como agonistas de m4 | |
| MX2022005415A (es) | Compuesto de imidazolidinona, metodo de preparacion del mismo y uso del mismo. |